Celledonia™ enhances the development and manufacture of cell-based therapeutics by providing rapid, label-free insight into the health and functional state of target cells throughout the process. By measuring intrinsic cell properties without markers or complex assays, Celledonia™ enables therapy developers to make confident, data-driven decisions that improve process consistency and accelerate development timelines.

Implement predictive cell analytics to:

• Gain workflow efficiency: Streamline analytics and reduce time, cost, and complexity across apheresis, transduction, and manufacturing workflows.
• Predict optimal starting material: Assess apheresis quality and cellular fitness to improve downstream performance.
• Monitor transduction and activation: Track T-cell activation, transduction efficiency, and CAR expression using rapid, label-free measurements.
• Enable process monitoring: Follow cellular changes from donor material through transduction, expansion, and harvest to support predictive process control
• Enable rapid, small volume release testing through Multiplex-Analysis – analyse multiple cell characteristics simultaneously from as little as a 50µm sample
• Employ quantitative analysis – Count cells, measure concentration, and track population dynamics – for single cells and entire populations.

Case Studies click here